Share Twitter LinkedIn Facebook Email Joan Schiller, MD, shares Keynote 189 and whether the data impacts her view of PDL-1 expression and patient selection at the 2018 Annual Meeting. Advertisement
ASCO 2025: Lung Cancer Immunotherapy Breakthroughs from the Immuno-Oncology Symposium Lung Cancer Treatment 4 Mins Read